Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy

Supportive Care in Cancer

Volumn 21, Issue 1, 2013, Pages 327-332

  Peterson, Douglas E ^a   Öhrn, Kerstin ^b   Bowen, Joanne ^c   Fliedner, Monica ^d   Lees, Judith ^e   Loprinzi, Charles ^f   Mori, Takehiko ^g   Osaguona, Anthony ^h   Weikel, Dianna S ⁱ   Elad, Sharon ^j   Lalla, Rajesh V ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b DALARNA UNIVERSITY   (Sweden)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF BERN   (Switzerland)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

^f MAYO CLINIC   (United States)

^g KEIO UNIVERSITY   (Japan)

^h UNIVERSITY OF BENIN   (Nigeria)

ⁱ UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^j UNIVERSITY OF ROCHESTER   (United States)

more..

Author keywords

Cancer; Oral cryotherapy; Oral mucositis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EDATREXATE; ETOPOSIDE; FLUOROURACIL; MELPHALAN; MITOMYCIN; VINBLASTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CRYOTHERAPY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; ORAL MUCOSITIS; PRACTICE GUIDELINE; PREVENTION STUDY; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; WHOLE BODY RADIATION;

CRYOTHERAPY; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; STOMATITIS;

EID: 84874112881     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1562-0     Document Type: Review

References (32)

1. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL (1991) Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452
2. Baydar M, Dikilitas M, Sevinc A, Aydogdu I (2005) Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy. J Natl Med Assoc 97:1161-1164
3. Cascinu S, Fedeli A, Fedeli SL, Catalano G (1994) Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil- induced stomatitis. Eur J Cancer B Oral Oncol 30B:234-236
4. Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A 3rd (1999) A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer 85:290-294
5. Nikoletti S, Hyde S, Shaw T, Myers H, Kristjanson LJ (2005) Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. J Clin Nurs 14:750-753
6. Papadeas E, Naxakis S, Riga M, Kalofonos C (2007) Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. Eur J Oncol Nurs 11:60-65
7. Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S (2008) Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer 112:1600-1606
8. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, Lifsey D, Glaw KC, Stevens BA, Hatfield AK, Vaught NL, Bartel J, Pierson N (1993) A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 72:2234-2238
9. Yokomizo H, Yoshimatsu K, Hashimoto M, Ishibashi K, Umehara A, Yoshida K, Fujimoto T, Watanabe K, Ogawa K (2004) Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis. Anticancer Res 24:1131-1134
10. Dreicer R, Propert KJ, Kuzel T, Kirkwood JM, O'Dwyer PJ, Loehrer PJ (1997) A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 20:251-253
11. Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB (1997) Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study. Cancer Chemother Pharmacol 41:75-78
12. Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F (1998) Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy. Invest New Drugs 16:69-75
13. Karagözoǧlu S, Filiz Ulusoy M (2005) Chemotherapy: the effect of oral cryotherapy on the development of mucositis. J Clin Nurs 14:754-765
14. Aisa Y, Mori T, Kudo M, Yashima T, Kondo S, Yokoyama A, Ikeda Y, Okamoto S (2005) Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer 13:266-269
15. Bhatt V, Vendrell N, Nau K, Crumb D, Roy V (2010) Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation. J Oncol Pharm Pract 16:195-204
16. Dumontet C, Sonnet A, Bastion Y, Salles G, Espinouse D, Coiffier B (1994) Prevention of high dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplant 14:492-494
17. Gori E, Arpinati M, Bonifazi F, Errico A, Mega A, Alberani F, Sabbi V, Costazza G, Leanza S, Borrelli C, Berni M, Feraut C, Polato E, Altieri MC, Pirola E, Loddo MC, Banfi M, Barzetti L, Calza S, Brignoli C, Bandini G, De Vivo A, Bosi A, Baccarani M (2007) Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo Nurses Group. Bone Marrow Transplant 39:347-352
18. Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L, Maloney DG, Press OW, Bensinger W (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031-1035
19. Mori T, Aisa Y, Yamazaki R, Mihara A, Ikeda Y, Okamoto S (2006) Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis. Bone Marrow Transplant 38:637-638
20. Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, Shigeta H, Ohue Y, Tasaka T, Kitanaka A, Kubota Y, Tanaka T, Ishida T, Miyake M (2008) Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Ann Hematol 87:837-845
21. Sato A, Saisho-Hattori T, Koizumi Y, Minegishi M, Iinuma K, Imaizumi M (2006) Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy. Tohoku J Exp Med 210:315-320
22. Svanberg A, Birgegard G, Ohrn K (2007) Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy - a randomized controlled trial. Support Care Cancer 15:1155-1161
23. Svanberg A, Ohrn K, Birgegard G (2010) Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial. J Clin Nurs 19:2146-2151
24. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG (2006) Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 85:690-700
25. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T (2010) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database System Rev: CD000978
26. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831
27. Drugs.com: http://www.drugs.com/pro/fluorouracil-injection.html (2012) accessed 27 Feb 2012
28. Grant SC, Kris MG, Young CW, Sirotnak FM (1993) Edatrexate, an antifolate with antitumor activity: a review. Cancer Invest 11:36-45
29. Bowen JM, Elad S, Hutchins R, Lalla R (2012) Methodology for the MASCC/ISOO mucositis clinical practice guidelines update. Support Care Cancer. doi: 10.1007/s00520-012-1592-7
30. Elad S, Bowen J, Zadik Y, Lalla RV (2012) Development of the MASCC/ISOO mucositis guidelines: considerations underlying the process. Support Care Cancer. doi: 10.1007/s00520-012-1593-6
31. Somerfield MR, Padberg JJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Class Pap Curr Comment 4:881-886
32. Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49:749-754